The Effectiveness of Diet Therapy on Malnutrition in Patients Resulting From Maintenance Hemodialysis

1980 ◽  
Vol 61 (6) ◽  
pp. 26-28
Author(s):  
M. A. Samsonov ◽  
V. M. Ermolenko ◽  
S. A. Agadjanov

Based on biochemical analyzes and clinical observation of 32 patients with end-stage renal failure on maintenance hemodialysis, a special 7G diet was developed, containing 60 g of protein (0.9-1.0 g per 1 kg of the patient's body weight) and the physiological norm of vitamins and minerals. substances.


2020 ◽  
Vol 16 (1) ◽  
pp. 107-120 ◽  
Author(s):  
David E. St-Jules ◽  
Mary R. Rozga ◽  
Deepa Handu ◽  
Juan Jesus Carrero

Background and objectivesHyperphosphatemia is a persistent problem in individuals undergoing maintenance hemodialysis, which may contribute to vascular and bone complications. In some dialysis centers, dietitians work with patients to help them manage serum phosphate. Given the regularity of hyperphosphatemia in this population and constraints on kidney dietitian time, the authors aimed to evaluate the evidence for this practice.Design, setting, participants, & measurementsThere was a systematic review and meta-analysis of clinical trials. MEDLINE, Embase, CINAHL, Web of Science, Cochrane Central Register of Controlled Trials, and other databases were searched for controlled trials published from January 2000 until November 2019 in the English language. Included studies were required to examine the effect of phosphate-specific diet therapy provided by a dietitian on serum phosphate in individuals on hemodialysis. Risk of bias and certainty of evidence were assessed using the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) method.ResultsOf the 8054 titles/abstracts identified, 168 articles were reviewed, and 12 clinical trials (11 randomized, one nonrandomized) were included. Diet therapy reduced serum phosphate compared with controls in all studies, reaching statistical significance in eight studies, although overall certainty of evidence was low, primarily due to randomization issues and deviations from protocol. Monthly diet therapy (20–30 minutes) significantly lowered serum phosphate in patients with persistent hyperphosphatemia for 4–6 months, without compromising nutrition status (mean difference, −0.87 mg/dl; 95% confidence interval, −1.40 to −0.33 mg/dl), but appeared unlikely to maintain these effects if discontinued. Unfortunately, trials were too varied in design, setting, and approach to appropriately pool in meta-analysis, and were too limited in number to evaluate the timing, dose, and strategy of phosphate-specific diet therapy.ConclusionsThere is low-quality evidence that monthly diet therapy by a dietitian appears to be a safe and efficacious treatment for persistent hyperphosphatemia in patients on HD.


2015 ◽  
Vol 85 (5-6) ◽  
pp. 348-355 ◽  
Author(s):  
Masamitsu Ubukata ◽  
Nobuyuki Amemiya ◽  
Kosaku Nitta ◽  
Takashi Takei

Abstract. Objective: Hemodialysis patients are prone to malnutrition because of diet or many uremic complications. The objective of this study is to determine whether thiamine deficiency is associated with regular dialysis patients. Methods: To determine whether thiamine deficiency is associated with regular dialysis patients, we measured thiamine in 100 patients undergoing consecutive dialysis. Results: Average thiamine levels were not low in both pre-hemodialysis (50.1 ± 75.9 ng/mL; normal range 24 - 66 ng/mL) and post-hemodialysis (56.4 ± 61.7 ng/mL). In 18 patients, post-hemodialysis levels of thiamine were lower than pre-hemodialysis levels. We divided the patients into two groups, the decrease (Δthiamine/pre thiamine < 0; - 0.13 ± 0.11) group (n = 18) and the increase (Δthiamine/pre thiamine> 0; 0.32 ± 0.21)) group (n = 82). However, there was no significance between the two groups in Kt/V or type of dialyzer. Patients were dichotomized according to median serum thiamine level in pre-hemodialysis into a high-thiamine group (≥ 35.5 ng/mL) and a low-thiamine group (< 35.4 ng/mL), and clinical characteristics were compared between the two groups. The low-thiamine value group (< 35.4 ng/ml; 26.8 ± 5.3 ng/ml) exhibited lower levels of serum aspartate aminotransferase and alanine aminotransferase than the high-thiamine value group (≥ 35.4 ng/ml; 73.5 ± 102.5 ng/ml) although there was no significance in nutritional marker, Alb, geriatric nutritional risk index , protein catabolic rate and creatinine generation rate. Conclusion: In our regular dialysis patients, excluding a few patients, we did not recognize thiamine deficiency and no significant difference in thiamine value between pre and post hemodialysis.


2006 ◽  
Vol 37 (S 1) ◽  
Author(s):  
A Mahmood ◽  
N Brereton ◽  
R Jones ◽  
A Moser ◽  
GV Raymond ◽  
...  
Keyword(s):  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 29-LB
Author(s):  
YUTA YOSHIZAWA ◽  
MICHIHIRO HOSOJIMA ◽  
HIDEYUKI KABASAWA ◽  
NAOHITO TANABE ◽  
TADAHIRO KITAMURA ◽  
...  

2020 ◽  
Vol 22 (2) ◽  
pp. 189-197
Author(s):  
N.A. Mikhaylova ◽  
◽  
S.V. Tishkina ◽  
V.M. Ermolenko ◽  
A.M. Kertsev ◽  
...  

2019 ◽  
Vol 31 (1) ◽  
pp. 53-62
Author(s):  
Hyunyoung Song ◽  
Wonsun Hwang ◽  
Won Jeong Kim

Sign in / Sign up

Export Citation Format

Share Document